Savonix to Present at Digital Medicine and Medtech Showcase 2019
SAN FRANCISCO--(BUSINESS WIRE)--Jan 4, 2019--Savonix, the mobile evidence-based digital neurocognitive assessment and brain health platform, today announced that Dr. Mylea Charvat, CEO and Founder, will present at the Digital Medicine & Medtech Showcase ™ 2019 Conference to be held January 7-9, 2019 in San Francisco, CA.
Savonix launched in Japan with a major insurance provider in December 2018. Savonix will be provided to policyholders to enable them to assess their brain health and motivate ongoing engagement to prevent cognitive impairment.
Presentation details are as follows:Date: Tuesday, January 8, 2019 Time: 10:30 – 10:45 AM Location: Powell – I (Level 3), Parc 55 San Francisco
More information about the Digital Medicine & Medtech Showcase 2019 Conference can be accessed here.
Connect with Savonix
Savonix delivers a fully mobile assessment of cognitive function available on Android and iOS for phone and tablet. Savonix Mobile is an accurate, accessible and affordable tool for professional cognitive screening. It empowers healthcare providers, payers and researchers to evaluate and leverage results to improve health and treatment outcomes. Led by clinical neuropsychologists, neuroscientists and IT leaders, Savonix sets the global standard on cognition and its relationship to risk, health outcomes and the development of innovative therapies. Savonix evidence-based tests are digitally validated versions of the gold standard cognition tests, many of which neuropsychologists have used effectively since the 1930s. For more information, please visit http://www.savonix.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190104005124/en/
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT OTHER TECHNOLOGY HEALTH RESEARCH OTHER SCIENCE SCIENCE GENERAL HEALTH
Copyright Business Wire 2019.
PUB: 01/04/2019 08:00 AM/DISC: 01/04/2019 08:01 AM